As Genesis Energy LP (GEL) Shares Declined, Shareholder Salient Capital Advisors Decreased by $7.55 Million Its Position; Asset Management Group Boosted Pfizer (PFE) Holding by $313,298; Shares Declined

Genesis Energy, L.P. (NYSE:GEL) Logo

Asset Management Group Inc increased its stake in Pfizer Inc (PFE) by 19.67% based on its latest 2018Q4 regulatory filing with the SEC. Asset Management Group Inc bought 7,286 shares as the company’s stock declined 4.08% while stock markets rallied. The institutional investor held 44,328 shares of the health care company at the end of 2018Q4, valued at $1.94M, up from 37,042 at the end of the previous reported quarter. Asset Management Group Inc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $231.95B market cap company. The stock increased 1.43% or $0.59 during the last trading session, reaching $41.78. About 70.94 million shares traded or 160.80% up from the average. Pfizer Inc. (NYSE:PFE) has risen 20.88% since March 17, 2018 and is uptrending. It has outperformed by 16.51% the S&P500. Some Historical PFE News: 10/04/2018 – Pfizer: No New Safety Signals Observed, Safety Profile Consistent With Known Safety Profile in Advance Renal Cell Carcinoma; 01/05/2018 – Pfizer Still Sees 2018 Adjusted R&D Expenses $7.4B-$7.9B; 08/03/2018 – PFIZER REPORTS FAVORABLE OUTCOME OF FDA ADVISORY COMMITTEE MEET; 08/05/2018 – XTALPI INC – STRATEGIC RESEARCH COLLABORATION WITH PFIZER TO DEVELOP A HYBRID PHYSICS- AND ARTIFICIAL INTELLIGENCE-POWERED SOFTWARE PLATFORM; 23/03/2018 – PFIZER SAYS HAS NOT YET MADE A DECISION, BUT CONTINUES TO EXPECT ONE IN 2018; 17/05/2018 – REG-INNATE PHARMA : Preliminary activity observed of the combination of monalizumab and durvalumab in patients with colorectal cancer; 10/04/2018 – TUBEROUS SCLEROSIS ALLIANCE SALUTES FDA APPROVAL OF AFINITOR® DISPERZ (EVEROLIMUS) AS THE FIRST ADJUNCTIVE TREATMENT APPROVED IN US FOR PATIENTS AGED 2 YEARS AND OLDER WITH TUBEROUS SCLEROSIS COMPLE…; 07/03/2018 – Pfizer breaks off a 5-year, $635M collaboration deal with CytomX, with nothing to show for it $PFE $CTMX; 17/05/2018 – PFIZER – RESULTS SHOWED ADJUNCTIVE TREATMENT WITH LYRICA 14 MG/KG/DAY RESULTED IN STATISTICALLY SIGNIFICANT REDUCTION IN SEIZURE FREQUENCY VS PLACEBO; 02/05/2018 – CDRD and Pfizer Canada Partner to Establish The CDRD Life Sciences Executive Institute

Salient Capital Advisors Llc decreased its stake in Genesis Energy LP (GEL) by 6.34% based on its latest 2018Q4 regulatory filing with the SEC. Salient Capital Advisors Llc sold 419,623 shares as the company’s stock declined 2.69% while stock markets rallied. The institutional investor held 6.20 million shares of the energy company at the end of 2018Q4, valued at $114.56M, down from 6.62 million at the end of the previous reported quarter. Salient Capital Advisors Llc who had been investing in Genesis Energy LP for a number of months, seems to be less bullish one the $2.77B market cap company. The stock increased 0.27% or $0.06 during the last trading session, reaching $22.62. About 1.26 million shares traded or 71.95% up from the average. Genesis Energy, L.P. (NYSE:GEL) has risen 6.47% since March 17, 2018 and is uptrending. It has outperformed by 2.10% the S&P500. Some Historical GEL News: 09/03/2018 – ClinicalTrial US: Micro-injections of Transparent Hyaluronic Acid Gel (Restylane® Silk) for Rejuvenation of the Aging Cheek; 07/05/2018 – Mallinckrodt: Information on H.P. Acthar Gel Posted on Website in Response to ’60 Minutes’ Report; 09/04/2018 – EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel; 11/04/2018 – Genesis Robotics Enters into Strategic Venture with Koch; 22/04/2018 – The 2018 Genesis G80 Sport is a great car with the wrong name; 22/05/2018 – SHAREHOLDER GENESIS INVESTMENT MANAGEMENT BUYS 5.6 PCT STAKES IN SOK MARKETLER SOKM.IS – KAP; 15/04/2018 – GENESIS ENERGY LTD – BARBARA CHAPMAN APPOINTED AS A NON-EXECUTIVE DIRECTOR; 17/05/2018 – Genesis Global Trading Granted BitLicense in New York State; 07/05/2018 – Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2; 23/03/2018 – ClinicalTrial US: Effectiveness of Locally Delivered Morus Alba Gel on Moderate Periodontitis

Since January 30, 2019, it had 0 insider purchases, and 1 insider sale for $1.81 million activity.

Investors sentiment decreased to 0.74 in Q4 2018. Its down 0.11, from 0.85 in 2018Q3. It worsened, as 42 investors sold PFE shares while 792 reduced holdings. 141 funds opened positions while 477 raised stakes. 4.05 billion shares or 2.27% more from 3.96 billion shares in 2018Q3 were reported. Greenleaf, Michigan-based fund reported 260,451 shares. Vigilant Capital Management Ltd holds 102,739 shares or 0.71% of its portfolio. Cape Ann Fincl Bank, a Massachusetts-based fund reported 30,504 shares. Us Natl Bank De, a Minnesota-based fund reported 7.88 million shares. Weik Cap Management holds 10,500 shares. Moreover, Private Wealth Prtn Ltd has 3.91% invested in Pfizer Inc. (NYSE:PFE). Portland Global Advisors Lc stated it has 0.34% in Pfizer Inc. (NYSE:PFE). Macguire Cheswick Tuttle Inv Counsel Ltd Llc owns 6,963 shares. Caledonia Invs Public Ltd Company accumulated 364,000 shares or 5.19% of the stock. Jennison Associate Ltd Liability stated it has 0.28% of its portfolio in Pfizer Inc. (NYSE:PFE). 580,164 are held by Fincl Counselors Inc. Great West Life Assurance Communications Can, Manitoba – Canada-based fund reported 6.43 million shares. Howe And Rusling invested in 0.7% or 76,265 shares. Chevy Chase Trust Holding Inc reported 4.95M shares. Karpus Management stated it has 6,509 shares or 0.01% of all its holdings.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “EC OKs Pfizer Avastin biosimilar – Seeking Alpha” on February 19, 2019, also Streetinsider.com with their article: “Pfizer (PFE) Prices $5B Debt Offering Consisting of Five Tranches of Notes – StreetInsider.com” published on March 05, 2019, Streetinsider.com published: “Pfizer (PFE) Reports FDA Approval of Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp) – StreetInsider.com” on March 12, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: 247Wallst.com and their article: “The 6 Most Shorted NYSE Stocks – 24/7 Wall St.” published on March 12, 2019 as well as Seekingalpha.com‘s news article titled: “FDA OKs Pfizer’s Herceptin biosimilar – Seeking Alpha” with publication date: March 12, 2019.

Asset Management Group Inc, which manages about $284.95 million and $243.51M US Long portfolio, decreased its stake in Vanguard Bond Index Short Term Bond Etf (BSV) by 16,775 shares to 10,549 shares, valued at $829,000 in 2018Q4, according to the filing. It also reduced its holding in Ishares Barclays Bd Fd 7 (IEF) by 6,384 shares in the quarter, leaving it with 44,776 shares, and cut its stake in Barclay’s Aggregate Bond Index I (AGG).

Analysts await Genesis Energy, L.P. (NYSE:GEL) to report earnings on May, 3. They expect $0.20 EPS, down 9.09% or $0.02 from last year’s $0.22 per share. GEL’s profit will be $24.52 million for 28.28 P/E if the $0.20 EPS becomes a reality. After $0.17 actual EPS reported by Genesis Energy, L.P. for the previous quarter, Wall Street now forecasts 17.65% EPS growth.

Investors sentiment decreased to 0.73 in 2018 Q4. Its down 0.19, from 0.92 in 2018Q3. It dived, as 16 investors sold GEL shares while 40 reduced holdings. 19 funds opened positions while 22 raised stakes. 87.54 million shares or 0.94% more from 86.72 million shares in 2018Q3 were reported. Novare Cap Management Ltd Liability Co accumulated 50,000 shares. Cincinnati Insur invested in 60,879 shares or 0.03% of the stock. Signaturefd Lc owns 7,575 shares or 0.01% of their US portfolio. Kings Point Mngmt holds 0% or 1,180 shares. Synovus Fincl holds 0% or 420 shares. Stifel Financial holds 251,838 shares. Goldman Sachs Gp has invested 0.01% in Genesis Energy, L.P. (NYSE:GEL). Jefferies Gru Limited Liability holds 6,760 shares or 0% of its portfolio. Texas Yale Cap owns 49,164 shares. Fmr Lc invested in 1 shares. Brown Brothers Harriman And Company, New York-based fund reported 3,930 shares. Horrell Mgmt reported 0.1% stake. Whittier Of Nevada holds 1,000 shares. 740,136 are held by Wells Fargo & Mn. Enterprise Fincl Svcs Corporation stated it has 1,517 shares or 0.02% of all its holdings.

More notable recent Genesis Energy, L.P. (NYSE:GEL) news were published by: Benzinga.com which released: “Earnings Scheduled For February 20, 2019 – Benzinga” on February 20, 2019, also Prnewswire.com with their article: “Cushing® Asset Management and Swank Capital Announce Rebalancing of The Cushing® Transportation Index – PRNewswire” published on February 21, 2019, Seekingalpha.com published: “More on Genesis Energy Q2 results – Seeking Alpha” on August 08, 2018. More interesting news about Genesis Energy, L.P. (NYSE:GEL) were released by: Benzinga.com and their article: “Mary’s Nutritionals, Free People Team To Sell CBD Wellness, Beauty Products – Benzinga” published on March 13, 2019 as well as Seekingalpha.com‘s news article titled: “Genesis Energy declares $0.55 dividend – Seeking Alpha” with publication date: January 10, 2019.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart